Procainamide Hydrochloride Injection, Solution
Product Images NDC 68083-604

This is a product description for Procainamide Hydrochloride Injection, USP, in a 1 gram/10 mL multiple-dose vial. Each milliliter contains Procainamide Hydrochloride 100 mg, methylparaben 1 mg as a preservative, and sodium metabisulfite 0.8 mg. It may also contain hydrochloric acid and/or sodium hydroxide for pH adjustment. The injection should not be used if it is darker than slightly yellow or shows any discoloration. It is advised to store the product at temperatures between 20°C to 25°C (68°F to 77°F). The manufacturer is Gland Pharma Limited located in Hyderabad, India. The product contains metabisulfites and has a specific lot/expiration date for reference.*

This text provides information about Procainamide Hydrochloride Injection, USP, with each 2 mL vial containing 1 gram of the solution (500 mg/mL). The injection contains procainamide hydrochloride, methylparaben as preservative, and sodium metabisulfite. It is manufactured by Gland Pharma Limited in India. The product may contain hydrochloric acid and/or sodium hydroxide for pH adjustment. The storage instructions include keeping it at 20°C to 25°C [68°F to 77°F]. Additionally, there is a warning that the injection contains metabisulfites.*

This is a description of Procainamide Hydrochloride Injection, USP, with a concentration of 1 gram per 10 mL (100 mg/mL). It is indicated for intramuscular or intravenous use. The drug contains metabisulfites and preservatives. It is a sterile, nonpyrogenic solution. The text also provides information on storage conditions, dosage guidance, and warnings related to the appearance of the solution. The product is manufactured by Gland Pharma Limited in India.*

This is a description of Procainamide Hydrochloride Injection, USP. It is available in multiple-dose vials containing 1 gram/10 mL (100 mg/mL) of the medication. Each milliliter of the solution contains procainamide hydrochloride along with other additives. The medication is stored between 20°C to 25°C. It is important to follow aseptic technique while using the injection and to check for discoloration before administration. The vials contain metabisulfites and are manufactured by Gland Pharma Limited.*

This is a product description for Procainamide Hydrochloride Injection, USP. It is available in 1 gram/2 mL vials and contains Melabisulfites. The product comes with a warning and instructions for use. Customers are advised to store the product at a controlled room temperature.*

This is a chemical formula for a compound with a molecular weight of 271.79 g/mol. The compound appears to contain elements such as nitrogen, oxygen, carbon, and hydrogen. The presence of HCl suggests that this compound may be a salt formed by reacting the compound with hydrochloric acid.*